- Home
- HMN vs CNTA Comparison
HMN vs CNTA Comparison
Compare HMN & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMN
- CNTA
- Stock Information
- Founded
- HMN 1945
- CNTA 2020
- Country
- HMN United States
- CNTA United Kingdom
- Employees
- HMN N/A
- CNTA N/A
- Industry
- HMN Property-Casualty Insurers
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- HMN Finance
- CNTA Health Care
- Exchange
- HMN Nasdaq
- CNTA Nasdaq
- Market Cap
- HMN 1.7B
- CNTA 1.9B
- IPO Year
- HMN 1991
- CNTA 2021
- Fundamental
- Price
- HMN $44.52
- CNTA $18.05
- Analyst Decision
- HMN Buy
- CNTA Strong Buy
- Analyst Count
- HMN 5
- CNTA 10
- Target Price
- HMN $46.75
- CNTA $30.56
- AVG Volume (30 Days)
- HMN 265.8K
- CNTA 1.1M
- Earning Date
- HMN 08-06-2025
- CNTA 08-12-2025
- Dividend Yield
- HMN 3.14%
- CNTA N/A
- EPS Growth
- HMN 71.62
- CNTA N/A
- EPS
- HMN 3.38
- CNTA N/A
- Revenue
- HMN $1,649,200,000.00
- CNTA $15,000,000.00
- Revenue This Year
- HMN $7.82
- CNTA N/A
- Revenue Next Year
- HMN $5.81
- CNTA N/A
- P/E Ratio
- HMN $13.17
- CNTA N/A
- Revenue Growth
- HMN 6.01
- CNTA 118.88
- 52 Week Low
- HMN $33.00
- CNTA $9.60
- 52 Week High
- HMN $45.27
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- HMN 63.38
- CNTA 68.40
- Support Level
- HMN $44.37
- CNTA $16.78
- Resistance Level
- HMN $45.18
- CNTA $17.37
- Average True Range (ATR)
- HMN 0.90
- CNTA 0.98
- MACD
- HMN 0.33
- CNTA 0.03
- Stochastic Oscillator
- HMN 82.98
- CNTA 98.04
About HMN Horace Mann Educators Corporation
Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.